National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 331 cases where Vaccine is HPV4 and Symptom is Death

Case Details

This is page 26 out of 34

Result pages: prev   17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34   next


VAERS ID: 573733 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-01-14
Entered: 2015-01-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Pulmonary embolism
SMQs:, Embolic and thrombotic events, venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions: GARDASIL, toleration was not reported
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1501DEU003164

Write-up: Information has been received from Sanofi Pasteur MSD (SPM) (MFR control# E2015-00044) on 09-JAN-2015. Case of fatal outcome was received from a healthcare professional on 07-Jan-2015. Case is medically confirmed. Case is linked with E2014-00045, -00046 and -00047 (same reporter, same vaccine, different reactions), with E2014-00048, -00049, -00050 and -00051 (same reporter, different vaccine, different reactions). A 16-year-old female patient received a second dose of GARDASIL (lot-no. not reported) on an unspecified date three to four years ago. Unspecified time later she developed a pulmonary embolism and died. It was unknown if the patient took oral contraceptives. First dose of GARDASIL was given on an unspecified date. Toleration was not reported.


VAERS ID: 575160 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Foreign  
Vaccinated:2013-06-01
Onset:2015-02-16
   Days after vaccination:625
Submitted: 2015-02-20
   Days after onset:4
Entered: 2015-02-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Death, Myalgia, Pyrexia, Respiratory arrest
SMQs:, Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Respiratory failure (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2015-02-20
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1502COL009207

Write-up: This spontaneous report as received from the patient''s parent (also reported as a friend of the mother''s patient) via a social webpage refers to a 16 year old female patient. In June 2013, the patient was vaccinated with a dose of GARDASIL (dose and lot # not reported) intramuscularly. In March 2014, the patient experienced fever, muscular pain and other symptoms (not specified) that the physician could not control, no diagnosis was done. The consumer also reported that on 16-FEB-2015, the patient experienced respiratory arrest and died. The outcome of fever and muscular pain was reported as not recovered/not resolved. The relationship between the events and GARDASIL was not reported. Upon internal review respiratory arrest was considered to be medically signfiicant. Additional information has been requested.


VAERS ID: 578747 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Foreign  
Vaccinated:2014-09-22
Onset:2014-10-01
   Days after vaccination:9
Submitted: 2015-05-19
   Days after onset:230
Entered: 2015-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. J015508 / 2 LA / IM

Administered by: Other       Purchased by: Other
Symptoms: Agitation, Death, Encephalitis, Headache, Seizure, Vomiting
SMQs:, Acute pancreatitis (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Dementia (broad), Convulsions (narrow), Noninfectious encephalitis (narrow), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Generalised convulsive seizures following immunisation (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1505BRA007659

Write-up: This spontaneous report was received via Business Partner: Institute (manufacturer control # was not provided so far) by a consumer (patient''s mother) and concerns a 14 years old non-pregnant female patient. Information about patient''s medical history was not provided. On an unknown date, the patient was vaccinated with the first dose of GARDASIL (dose: 0.5 ml, intramuscularly, lot# and anatomical location were unspecified). Then, on 22-SEP-2014, she was vaccinated with the second dose of GARDASIL (dose: 0.5 ml, intramuscularly, anatomical location reported as left deltoids) (lot # J015508, expiration date: 05-JUN-2016). On an unknown date in September 2014, the patient experienced vomiting, headache, agitation and generalized convulsion. These adverse events led patient to the emergency room on 24-SEP-2014. She was hospitalized since approximately the same day. On 01-OCT-2014, the patient was diagnosed with encephalitis. The patient died on an unknown date. It was unknown if autopsy was done. The outcome of encephalitis was reported as fatal. The outcome of agitation, vomiting, headache and generalized convulsion was unknown. The relatedness between the events and GARDASIL was not reported. Adverse event of generalized convulsion was considered to be medically significant event. Upon internal review, encephalitis was considered to be medically significant event. Additional information is not expected, as reporter could not provide patient''s physician contact details.


VAERS ID: 582025 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Foreign  
Vaccinated:2014-02-01
Onset:2015-05-01
   Days after vaccination:454
Submitted: 2015-06-11
   Days after onset:41
Entered: 2015-06-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Condition aggravated, Death, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Cardiac disorder; Systemic lupus erythematosus
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1506COL004105

Write-up: This spontaneous report was received a social media, TV news refers to a 16 year old female patient. The patient''s current condition included lupus and unspecified heart disease and medial history was not reported. On an unknown date in February 2014, the patient was vaccinated with second dose of GARDASIL (vial and prefilled syringe) intramuscularly (strength and frequency were not reported). Concomitant medications were not reported. On an unknown date after vaccination patient experienced fainting and worsening of pre-existing conditions (Lupus (death, life threatening and medically significant) and unspecified heart disease (death and life threatening). The outcome of worsening of pre-existing conditions (Lupus and unspecified heart disease) was reported as fatal. The outcome of fainting was unknown. The patient died on an unknown date in May 2015. The cause of death was unknown. The relatedness of the events with the quadrivalent human papillomavirus (types 6, 11, 16, 18) recomb. Vaccine was not reported. Upon internal review, worsening of pre-existing conditions (Lupus) was determined to be serious as another important medical event. Additional information is not expected as the contact details were not reported.


VAERS ID: 586489 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-07-20
Entered: 2015-07-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1507ESP008491

Write-up: Information has been received from Sanofi Pasteur MSD (manufacturer control number ES-1577272925-E2015-08215) on 17-JUL-2015. Case received from health care professional, published in a digital media on 13-JUL-2015. Case medically confirmed. An adolescent female patient with none medical history reported, had received an unspecified number of doses of a human papillomavirus vaccine (manufacturer not reported, batch number not reported), route not reported, date of administration not reported, and later (date not reported) she died. According to the newspaper it has not been clarified yet if the event could be a complication of the vaccine or not. No further information was reported.


VAERS ID: 588577 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-07-28
Entered: 2015-07-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1507GBR011813

Write-up: Information has been received from Sanofi Pasteur MSD (Sender case report number GB-1577272925-E2015-08469) on 24-JUL-2015. Serious case received from a consumer via lay press on 19/Jul/2015. This case is not medically confirmed. This case is linked to E2015-08375 (same reporter). An unknown number of female patients of unreported age, with no concomitant medication reported, received injections of GARDASIL, (batch number not reported), series site and route not reported, on unreported date. The majority of the teenagers were perfectly healthy prior to vaccination. On unreported dates, some young people have died following vaccination with most post mortem results unable to show a conclusive cause of death. A petition, from the Agency of HPV Vaccine Injured Patients, stated that there was a growing pattern of illness emerging among young girls since the vaccine was introduced. The agency has been contacted by more than 130 families since 2008 and more than half of these have come forward indicating the rate was accelerating. The case was considered serious for death.


VAERS ID: 607369 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: Foreign  
Vaccinated:2013-05-03
Onset:2015-08-06
   Days after vaccination:825
Submitted: 2015-08-13
   Days after onset:7
Entered: 2015-08-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Death, Demyelinating polyneuropathy, Diarrhoea, Dizziness, Headache, Hypoaesthesia, Mobility decreased, Movement disorder, Pyrexia, Quadriplegia, Respiratory arrest, Vomiting
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Peripheral neuropathy (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Pseudomembranous colitis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Akathisia (broad), Dyskinesia (broad), Dystonia (broad), Parkinson-like events (broad), Acute central respiratory depression (narrow), Guillain-Barre syndrome (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Demyelination (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Vestibular disorders (broad), Hypersensitivity (broad), Noninfectious diarrhoea (narrow), Respiratory failure (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2015-08-06
   Days after onset: 0
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: 10/2013, Body temperature, Fever
CDC Split Type: WAES1508COL004387

Write-up: This spontaneous report was received from the local news (local radio, television, and online newspaper) concerning to a female patient of approximately 19 to 20 years (discrepancy among media news). Information regarding the patient''s medical history, concurrent conditions or concomitant therapy was not provided. On an unspecified date in May 2013, the patient was vaccinated with the first dose of GARDASIL 0.5 ml injection (strength, lot number and expiration date were not provided), 0.5 ml intramuscular. Subsequently, on an also unspecified date in May 2013, after the vaccination, the patient experienced muscle numbness, movement disorder (no specific description was provided) and dizziness. On 25-OCT-2013, the patient was vaccinated with the second dose of GARDASIL 0.5 ml injection (strength, lot number and expiration date were not provided), 0.5 ml intramuscular. On the same month, also after vaccination, the patient experienced headache, diarrhoea, vomiting and pyrexia. Later, on an unknown date in 2014, the patient experienced mobility decreased in her limbs. Then on the same year, she got quadriplegic and, according to the news, in 2014, she was diagnosed with demyelinating polyneuropathy (there was no exact description or clear information concerning when or where the diagnosis was given). In 2015, the patient experienced the first respiratory arrest and recovered from it on an unknown date in the same year. Consequently, on 06-AUG-2015 at 19:-00, the patient experienced the second respiratory arrest and died from it. It was unknown if an autopsy was performed. At the time of this report, the patient had not recovered from quadriplegia. The outcome of demyelinating polyneuropathy, vomiting, pyrexia, headache, dizziness, diarrhoea, hypoaesthesia, movement disorder and mobility decreased was unknown. Additional information is not expected because contact information is not available.


VAERS ID: 607675 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-08-21
Entered: 2015-08-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1508NZL009159

Write-up: The spontaneous report was received from Regulatory Authority regarding a patient of unknown age and gender. The patient''s medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with GARDASIL dose, route unknown. Concomitant medications were not reported. On an unknown date the patient died due to sudden death. The pathologist was investigating the possibility of a heridatory cardiac conduction problem. The reporter considered sudden death to be not related to GARDASIL. This is one of several reports received from the same reporter. Additional information is not expected from the Agency as follow up information cannot be obtained.


VAERS ID: 607719 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-08-21
Entered: 2015-08-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Wrong drug administered
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1508NZL009160

Write-up: This spontaneous report was received from a Regulatory Authority regarding a baby of unknown age and gender. The patient''s medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with GARDASIL dose, route unknown. Concomitant medications were not reported. On an unknown date the GARDASIL was administered to a baby which was a medication error. The baby died after two years of the medication error. The reporter considered death to be not related to GARDASIL. This is one of several reports received from the same reporter. Additional information is not expected from the Agency as follow up information cannot be obtained.


VAERS ID: 608029 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-08-26
Entered: 2015-08-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Adverse event, Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1508COL009556

Write-up: This spontaneous report was received from a journalist in an article published in a local newspaper regarding a female patient of unknown age. The patient''s concurrent conditions and medical history were not reported. On an unknown date, the patient was vaccinated with GARDASIL (strength, dose, frequency and route were not reported). Concomitant medications were not reported. On an unknown date, the patient experienced adverse events (not reported) associated with vaccine administration, which lead to the death of the patient. The outcome of adverse event was reported as fatal. The reporter did not provide the causality between the event and the suspect therapy. Additional information is not expected as there are no contact details available for further follow-up.


Result pages: prev   17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=26&SYMPTOMS[]=Death_%2810011906%29&VAX[]=HPV4


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166